<DOC>
	<DOCNO>NCT01892904</DOCNO>
	<brief_summary>The multi-center , randomize , open-label , active-controlled , parallel-group comparative study ( 24-week treatment period ) . The objective study prove superiority BAY 86-5300 flexible extended regimen treatment dysmenorrhea BAY 86-5300 28-day cyclic regimen term primary efficacy variable , number day dysmenorrheic pain 140 day evaluation period . In addition , long-term safety flexible extended regimen BAY86-5300 patient treat one year investigate .</brief_summary>
	<brief_title>Comparative Study BAY86-5300 With Flexible Extended Regimen Dysmenorrhea</brief_title>
	<detailed_description />
	<mesh_term>Dysmenorrhea</mesh_term>
	<mesh_term>Drospirenone</mesh_term>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<criteria>Dysmenorrhea patient total dysmenorrhea score ( sum two subscores : severity dysmenorrhea use analgesic ) least 3 point last two menstruation randomization ( baseline observation phase ) Patients dysmenorrheic pain 2 baseline cycle randomization . Dysmenorrheic pain mean spasmodic pelvic pain lower abdominal pain possible radiation towards back thighs record Patient Diary correspondence withdrawal and/or menstrual bleeding episode . Pain could start 2 day onset bleeding episode bleed terminates last day bleed Patients regular cyclic menstrual period ( 25 38 day ) late two menses randomization ( baseline observation phase ) Willingness use barrier method ( i.e. , nonhormonal method ) contraception study . Acceptable method contraception include ( ) condom ( male female ) without spermicidal agent ; ( ii ) diaphragm cervical cap spermicide ; ( iii ) intrauterine device . Patients organic disease surgical treatment prioritize investigator Patients age 40 year old ovarian chocolate cyst 10 cm size long diameter Patients ovarian chocolate cyst solid part cyst Patients YAZ Combination Tablet contraindicate ( accord Japanese Labeling )</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>YAZ</keyword>
	<keyword>Flexible regimen</keyword>
	<keyword>Drospirenone</keyword>
	<keyword>Ethinylestradiol Betadex</keyword>
	<keyword>Dysmenorrhea</keyword>
	<keyword>Japanese patient</keyword>
</DOC>